Artwork

Content provided by podcastcp and China Plus. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by podcastcp and China Plus or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Why foreign firms are betting big on China's biopharma future

55:00
 
Share
 

Manage episode 489851601 series 3343901
Content provided by podcastcp and China Plus. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by podcastcp and China Plus or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

China's biopharma boom is on, and foreign investors are flooding in. As we dive into the billion-dollar wave of foreign investment reshaping China's biotech landscape, check out Why pharma giants like Roche and AstraZeneca are expanding their footprint here. What strategic edge does China offer in global drug development? And can the country become a global biopharma innovation powerhouse by 2030?

Host Tu Yun joins Dr. Zhou Mi, the Deputy Director of the Institute of American and Oceania Study, Chinese Academy of International Trade and Economic Cooperation,

  continue reading

105 episodes

Artwork
iconShare
 
Manage episode 489851601 series 3343901
Content provided by podcastcp and China Plus. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by podcastcp and China Plus or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

China's biopharma boom is on, and foreign investors are flooding in. As we dive into the billion-dollar wave of foreign investment reshaping China's biotech landscape, check out Why pharma giants like Roche and AstraZeneca are expanding their footprint here. What strategic edge does China offer in global drug development? And can the country become a global biopharma innovation powerhouse by 2030?

Host Tu Yun joins Dr. Zhou Mi, the Deputy Director of the Institute of American and Oceania Study, Chinese Academy of International Trade and Economic Cooperation,

  continue reading

105 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play